Answers are grounded in this paper and cite their sources.
The serotonin/noradrenaline reuptake inhibitor rac -1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol ( rac -venlafaxine, rac - 1a ) is in clinical use as an antidepressant. The silicon analogue, rac -1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-1-silacyclohexan-1-ol ( rac -sila-venlafaxine, rac - 1b ), was synthesized in multistep syntheses, starting from tetrachlorosilane or tetramethoxysilane. The corresponding 1-silacyclopentan-1-ol derivative rac - 2 was prepared analogously. The sila-venlafaxine enantiomers ( R )- 1b and ( S )- 1b were obtained by resolution of rac - 1b, using (+)- or (−)-10-camphorsulfonic acid as the resolving agent. Compounds rac - 1b, ( R )- 1b, ( S )- 1b, rac - 1b ·HCl, ( R )- 1b ·HCl, ( S )- 1b ·HCl, ( R )- 1b ·HBr, rac - 2, and rac - 2 ·HCl were characterized by multinuclear NMR studies and elemental analyses, and rac - 1b ·HCl, ( R )- 1b ·HBr, and rac - 2 were additionally characterized by crystal structure analyses. Compounds rac - 1a, rac - 1b, rac - 2, ( R )- 1a, ( S )- 1a, ( R )- 1b, and ( S )- 1b were tested as their hydrochlorides for their efficacy in serotonin, noradrenaline, and dopamine reuptake inhibition assays. Sila-substitution (C/Si switch) of compounds rac - 1a, ( R )- 1a, and ( S )- 1a (→ rac - 1b, ( R )- 1b, ( S )- 1b ) was found to dramatically influence their pharmacological selectivity profiles with respect to serotonin, noradrenaline, and dopamine reuptake inhibition. ( R )-Sila-venlafaxine (( R )- 1b ) was identified to have a refined selectivity profile consistent with selective noradrenaline reuptake inhibition. Compounds with this profile may provide therapeutic benefit in the treatment of various nervous system disorders.
No takes yet. Share an insight, caveat, or question.
Daiss et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: